New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Vitamin D and Tooth Health: What You Need to Know

Vitamin D and Tooth Health: What You Need to Know

Fitness and Wellness| ByMaria Santos |March 8, 2023Share• Vitamin D plays an important role in maintaining the strength of teeth and bones.• Low vitamin D levels can lead to we
Stomatology October 10,2023
Vitamin D and Tooth Health: What You Need to Know

Vitamin D and Tooth Health: What You Need to Know

Fitness and Wellness| ByMaria Santos |March 8, 2023Share• Vitamin D plays an important role in maintaining the strength of teeth and bones.• Low vitamin D levels can lead to we
Stomatology October 10,2023
KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t
Oncology October 10,2023
KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

September 26, 2023Pankit Vachhani, MD Prithviraj Bose, MDThe hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal t
Oncology October 10,2023
European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients
Oncology October 09,2023
European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients
Oncology October 09,2023
Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch
Oncology October 09,2023
Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch
Oncology October 09,2023
American Society of Plastic Surgeons Reveals 2022's Most Sought-After Procedures

American Society of Plastic Surgeons Reveals 2022's Most Sought-After Procedures

World's Largest Plastic Surgeon Organization Finds Increase in Procedures Amidst Growing Social Acceptance and Continued Innovations· Tuesday, Sept
Plastic Surgery October 09,2023
American Society of Plastic Surgeons Reveals 2022's Most Sought-After Procedures

American Society of Plastic Surgeons Reveals 2022's Most Sought-After Procedures

World's Largest Plastic Surgeon Organization Finds Increase in Procedures Amidst Growing Social Acceptance and Continued Innovations· Tuesday, Sept
Plastic Surgery October 09,2023
New ADA guideline recommends acetaminophen, NSAIDs to manage pain in pediatric patients

New ADA guideline recommends acetaminophen, NSAIDs to manage pain in pediatric patients

Association policy supports opioid prescription limits, mandatory CE for dentistsAnew clinical practice guideline from the American Dental Associationrecommends acetaminophen or nonsteroid
Pediatrics October 08,2023
New ADA guideline recommends acetaminophen, NSAIDs to manage pain in pediatric patients

New ADA guideline recommends acetaminophen, NSAIDs to manage pain in pediatric patients

Association policy supports opioid prescription limits, mandatory CE for dentistsAnew clinical practice guideline from the American Dental Associationrecommends acetaminophen or nonsteroid
Pediatrics October 08,2023
I’m a dentist. I’m begging people not to give up on aspartame

I’m a dentist. I’m begging people not to give up on aspartame

ByMelissa WeintraubAug. 14, 2023ReprintsADOBEThe International Agency for Research on Cancer (IARC, an entity within the World Health Organization) recentlyannouncedthat aspartame, a
Stomatology October 08,2023
I’m a dentist. I’m begging people not to give up on aspartame

I’m a dentist. I’m begging people not to give up on aspartame

ByMelissa WeintraubAug. 14, 2023ReprintsADOBEThe International Agency for Research on Cancer (IARC, an entity within the World Health Organization) recentlyannouncedthat aspartame, a
Stomatology October 08,2023
New comprehensive review strengthens case for 'oral-gut axis'

New comprehensive review strengthens case for 'oral-gut axis'

by Stephanie Baum , Medical XpressOral pathogen-mediated immune responses that drive gut inflammation in IBD. Periodontitis onset triggers expansion of pathogenic oral bacteria. Constant saliva swallo
Stomatology October 08,2023
New comprehensive review strengthens case for 'oral-gut axis'

New comprehensive review strengthens case for 'oral-gut axis'

by Stephanie Baum , Medical XpressOral pathogen-mediated immune responses that drive gut inflammation in IBD. Periodontitis onset triggers expansion of pathogenic oral bacteria. Constant saliva swallo
Stomatology October 08,2023
Dentists identify new bacterial species involved in tooth decay

Dentists identify new bacterial species involved in tooth decay

Large study in children reveals Selenomonas sputigena as a key partner of Streptococcus in cavity formation.Date:June 8, 2023Source:University of PennsylvaniaSummary:Large study in children reveals Se
Stomatology October 08,2023
Dentists identify new bacterial species involved in tooth decay

Dentists identify new bacterial species involved in tooth decay

Large study in children reveals Selenomonas sputigena as a key partner of Streptococcus in cavity formation.Date:June 8, 2023Source:University of PennsylvaniaSummary:Large study in children reveals Se
Stomatology October 08,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com